Join us for an insightful webinar, where experts will shed light on the multifaceted role of fibrosis in various health conditions.
Our presentations will cover a wide array of topics, starting with an exploration of the fundamentals of the extracellular matrix in health and disease, emphasizing the impact of fibroblast activity on outcomes. The complex relationship between liver fibrosis and hepatocellular carcinoma (HCC) will be explored, examining whether fibrosis is a cause or consequence of this condition.
Further discussions will delve into the extracellular matrix of cancers and the modulation of the ECM, providing insights into the interplay between fibrosis and cancer outcomes. Lastly, we’ll explore collagen biomarkers and their role in predicting outcomes related to liver, heart, and HCC.
This webinar offers a unique opportunity to gain comprehensive insights into the role of fibrosis in driving outcomes across various health conditions with a common component, providing valuable knowledge for researchers, clinicians, and healthcare professionals alike.
0:00 Intro
6:20 Fibroblast Activity Kills - Dr. Morten A. Karsdal
18:03 The ECM of Cancers and The Modulation of the ECM - Dr. Raghu Kalluri
49:50 Collagen biomarkers of Liver, Heart, and HCC Outcome - Dr. Diana Julie Leeming
1:11:40 Liver Fibrosis and HCC - Cause or Consequence? - Dr. Scott Friedman
1:31:50 Questions from the chat​​​​​​​
#fibrosis #cancer #liver #cardiology #drugdevelopment #webinar